Literature DB >> 20521329

Wnt3a activates dormant c-Kit(-) bone marrow-derived cells with short-term multilineage hematopoietic reconstitution capacity.

Jennifer J Trowbridge1, Borhane Guezguez, Randall T Moon, Mickie Bhatia.   

Abstract

Quiescent cells lacking expression of mature lineage makers and the c-Kit receptor reside in adult bone marrow. Despite their phenotypic similarity to hematopoietic stem cells, these Lin(-)Sca-1(+)c-Kit(-) cells lack myeloid and erythroid potential and long-term hematopoietic repopulating capacity, whereas, recent studies have functionally demonstrated that the Lin(-)Sca-1(+)c-Kit(-) population contains early lymphoid-committed progenitors. Examining the role of Wnt signaling in regulation of this population, we found that c-Kit(-) cells express diverse Wnt receptors and proliferate upon Wnt pathway activation in vitro and in vivo. Stimulation with Wnt3a, but not Wnt5a or Wnt11, promoted c-Kit(-) cells to give rise to myeloid and erythroid progenitors with robust self-renewal capacity measured by clonal replating. In addition, Wnt3a-stimulated c-Kit(-) cells gave rise to all hematopoietic lineages (lymphoid, myeloid, and erythroid) upon transplant into the liver of newborn recipient mice. Our study reveals that Wnt3a activates unique cell fate decisions of dormant c-Kit(-) that promotes short-term multilineage reconstitution capacity in vivo, thereby revealing a unique role for Wnt activation in hematopoiesis. Overall, our results highlight the potential of utilizing signaling molecules known to have instructive roles in regeneration to discover cell subsets residing in adult organisms with unexploited regenerative capacity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521329     DOI: 10.1002/stem.457

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  13 in total

1.  Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells.

Authors:  Janina Ratajczak; Marcin Wysoczynski; Ewa Zuba-Surma; Wu Wan; Magda Kucia; Mervin C Yoder; Mariusz Z Ratajczak
Journal:  Exp Hematol       Date:  2010-10-27       Impact factor: 3.084

Review 2.  Biomaterial strategies for stem cell maintenance during in vitro expansion.

Authors:  Xiang-Zhen Yan; Jeroen J J P van den Beucken; Sanne K Both; Pi-Shan Yang; John A Jansen; Fang Yang
Journal:  Tissue Eng Part B Rev       Date:  2013-12-05       Impact factor: 6.389

3.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

Review 4.  Targeting Wnt pathways in disease.

Authors:  Zachary F Zimmerman; Randall T Moon; Andy J Chien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

5.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.

Authors:  Moshe Elkabets; Ann M Gifford; Christina Scheel; Bjorn Nilsson; Ferenc Reinhardt; Mark-Anthony Bray; Anne E Carpenter; Karin Jirström; Kristina Magnusson; Benjamin L Ebert; Fredrik Pontén; Robert A Weinberg; Sandra S McAllister
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

6.  Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow.

Authors:  Adipong Brickshawana; Virginia Smith Shapiro; Hirohito Kita; Larry R Pease
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

7.  Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals.

Authors:  Philipp Leucht; Jie Jiang; Du Cheng; Bo Liu; Girija Dhamdhere; Mark Yang Fang; Stefanie D Monica; Jonathan J Urena; Whitney Cole; Lane R Smith; Alesha B Castillo; Michael T Longaker; Jill A Helms
Journal:  J Bone Joint Surg Am       Date:  2013-07-17       Impact factor: 5.284

8.  WNT3A promotes hematopoietic or mesenchymal differentiation from hESCs depending on the time of exposure.

Authors:  Karin Gertow; Claire E Hirst; Qing C Yu; Elizabeth S Ng; Lloyd A Pereira; Richard P Davis; Edouard G Stanley; Andrew G Elefanty
Journal:  Stem Cell Reports       Date:  2013-06-04       Impact factor: 7.765

9.  Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34(+)CD38(-) Cells.

Authors:  Kamonnaree Chotinantakul; Patcharee Prasajak; Wilairat Leeanansaksiri
Journal:  Stem Cells Int       Date:  2013-08-20       Impact factor: 5.443

Review 10.  Wnt3a: functions and implications in cancer.

Authors:  Sha He; Yi Lu; Xia Liu; Xin Huang; Evan T Keller; Chao-Nan Qian; Jian Zhang
Journal:  Chin J Cancer       Date:  2015-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.